Antidepressant use during pregnancy and serotonin transporter genotype (SLC6A4) Affect newborn serum reelin levels

Developmental Psychobiology

Volumn 55, Issue 5, 2013, Pages 518-529

  Brummelte, S ^a,b   Galea, L A M ^a,c   Devlin, A M ^a,b   Oberlander, T F ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antenatal depression; Development; Gestation; Infant; Mood; Neurobehavioral assessment of the preterm infant; Selective serotonin reuptake inhibitors; Serotonin norepinephrine reuptake inhibitor

Indexed keywords

ANTIDEPRESSANT AGENT; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; DEPRESSION; FEMALE; GENETICS; GENOTYPE; HUMAN; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIDEPRESSIVE AGENTS; CELL ADHESION MOLECULES, NEURONAL; DEPRESSIVE DISORDER; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SERINE ENDOPEPTIDASES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 84878882863     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.21056     Document Type: Article

References (65)

1. Ammassari-Teule, M., Sgobio, C., Biamonte, F., Marrone, C., Mercuri, N. B., & Keller, F. (2009). Reelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors. Psychopharmacology (Berlin), 204, 511-521.
2. Barr, A. M., Fish, K. N., Markou, A., & Honer, W. G. (2008). Heterozygous reeler mice exhibit alterations in sensorimotor gating but not presynaptic proteins. European Journal of Neuroscience, 27, 2568-2574.
3. Botella-Lopez, A., Burgaya, F., Gavin, R., Garcia-Ayllon, M. S., Gomez-Tortosa, E., Pena-Casanova, J., ... Saez-Valero, J. (2006). Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 103, 5573-5578.
4. Brigman, J. L., Padukiewicz, K. E., Sutherland, M. L., & Rothblat, L. A. (2006). Executive functions in the heterozygous reeler mouse model of schizophrenia. Behavioral Neuroscience, 120, 984-988.
5. Canli, T., & Lesch, K. P. (2007). Long story short: The serotonin transporter in emotion regulation and social cognition. Nature Neuroscience, 10, 1103-1109.
6. Capello, C. F., Bourke, C. H., Ritchie, J. C., Stowe, Z. N., Newport, D. J., Nemeroff, A., & Owens, M. J. (2011). Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk. Journal of Pharmacology and Experimental Therapeutics, 339, 275-285.
7. Caspi, A., Hariri, A. R., Holmes, A., Uher, R., & Moffitt, T. E. (2010). Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. American Journal of Psychiatry, 167, 509-527.
8. Chameau, P., Inta, D., Vitalis, T., Monyer, H., Wadman, W. J., & van Hooft, J. A. (2009). The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proceedings of the National Academy of Sciences of the United States of America, 106, 7227-7232.
9. Costa, E., Davis, J., Pesold, C., Tueting, P., & Guidotti, A. (2002). The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Current Opinion in Pharmacology, 2, 56-62.
10. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68(11), 1104-1112.
11. Curran, T., & D'Arcangelo, G. (1998). Role of reelin in the control of brain development. Brain Research. Brain Research Reviews, 26, 285-294.
12. D'Arcangelo, G., Miao, G. G., Chen, S. C., Soares, H. D., Morgan, J. I., & Curran, T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374, 719-723.
13. Falconer, D. S. (1951). Two new mutants, trembler and reeler, with neurological actions in the house mouse (mus-musculus). Journal of Genetics, 50, 192-201.
14. Fatemi, S. H. (2002). The role of reelin in pathology of autism. Molecular Psychiatry, 7, 919-920.
15. Fatemi, S. H., Earle, J. A., & McMenomy, T. (2000). Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Molecular Psychiatry, 5, 654-663, 571.
16. Fatemi, S. H., Kroll, J. L., & Stary, J. M. (2001). Altered levels of reelin and its isoforms in schizophrenia and mood disorders. Neuroreport, 12, 3209-3215.
17. Fatemi, S. H., Snow, A. V., Stary, J. M., Araghi-Niknam, M., Reutiman, T. J., Lee, S., ... Pearce, D. A. (2005). Reelin signaling is impaired in autism. Biological Psychiatry, 57, 777-787.
18. Fatemi, S. H., Stary, J. M., & Egan, E. A. (2002). Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cellular and Molecular Neurobiology, 22, 139-152.
19. Field, T. (2010). Prenatal depression and selective serotonin reuptake inhibitors. International Journal of Neuroscience, 120, 163-167.
20. Forster, E., Bock, H. H., Herz, J., Chai, X., Frotscher, M., & Zhao, S. (2010). Emerging topics in reelin function. European Journal of Neuroscience, 31, 1511-1518.
21. Goes, F. S., Willour, V. L., Zandi, P. P., Belmonte, P. L., MacKinnon, D. F., Mondimore, F. M., ... Potash, J. B. (2010). Sex-specific association of the reelin gene with bipolar disorder. American Journal of Medical Genetics Part B, 153B, 549-553.
22. Gressier, F., Bouaziz, E., Verstuyft, C., Hardy, P., Becquemont, L., & Corruble, E. (2009). 5-HTTLPR modulates antidepressant efficacy in depressed women. Psychiatric Genetics, 19, 195-200.
23. Guidotti, A., Auta, J., Davis, J. M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., ... Costa, E. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Archives of General Psychiatry, 57, 1061-1069.
24. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
25. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66, 2621-2624.
26. Homberg, J. R., & Lesch, K. P. (2011). Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry, 69, 513-519.
27. Homberg, J. R., Schubert, D., & Gaspar, P. (2010). New perspectives on the neurodevelopmental effects of SSRIs. Trends in Pharmacological Sciences, 31, 60-65.
28. Hyman, C., Snider, L. M., Majnemer, A., & Mazer, B. (2005). Concurrent validity of the neurobehavioural assessment for pre-term infants (NAPI) at term age. Pediatric Rehabilitation, 8, 225-234.
29. Ikeda, Y., & Terashima, T. (1997). Expression of reelin, the gene responsible for the reeler mutation, in embryonic development and adulthood in the mouse. Developmental Dynamics, 210, 157-172.
30. Janusonis, S., Gluncic, V., & Rakic, P. (2004). Early serotonergic projections to Cajal-Retzius cells: Relevance for cortical development. Journal of Neuroscience, 24, 1652-1659.
31. Jossin, Y., Gui, L., & Goffinet, A. M. (2007). Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. Journal of Neuroscience, 27, 4243-4252.
32. Jossin, Y., Ignatova, N., Hiesberger, T., Herz, J., Lambert de Rouvroit, C., & Goffinet, A. M. (2004). The central fragment of reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. Journal of Neuroscience, 24, 514-521.
33. Kim, D. K., Lim, S. W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., & Carroll, B. J. (2000). Serotonin transporter gene polymorphism and antidepressant response. Neuroreport, 11, 215-219.
34. Kim, J., Riggs, K. W., Misri, S., Kent, N., Oberlander, T. F., Grunau, R. E., ... Rurak, D. W. (2006). Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. British Journal of Clinical Pharmacology, 61, 155-163.
35. Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T., & Suzuki, H. (2010). Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proceedings of the National Academy of Sciences of the United States of America, 107, 8434-8439.
36. Kobold, D., Grundmann, A., Piscaglia, F., Eisenbach, C., Neubauer, K., Steffgen, J., ... Knittel, T. (2002). Expression of reelin in hepatic stellate cells and during hepatic tissue repair: A novel marker for the differentiation of HSC from other liver myofibroblasts. Journal of Hepatology, 36, 607-613.
37. Kohno, S., Kohno, T., Nakano, Y., Suzuki, K., Ishii, M., Tagami, H., ... Hattori, M. (2009). Mechanism and significance of specific proteolytic cleavage of reelin. Biochemical and Biophysical Research Communications, 380, 93-97.
38. Koren, G., & Boucher, N. (2009). Adverse effects in neonates exposed to SSRIs and SNRI in late gestation-Motherisk update 2008. The Canadian Journal of Clinical Pharmacology, 16, e66-e67.
39. Korner, A. F., Brown, J. V., Thom, V. A., & Constantinou, J. C. (2000). Neurobehavioral assessment of the preterm infant revised. (2nd ed.). Van Nuys: Child Development Media, Inc.
40. Korner, A. F., & Constantinou, J. (2001). The neurobehavioral assessment of the preterm infant. New York: The Guildford Press.
41. Korner, A. F., Constantinou, J., Dimiceli, S., Brown, B. W. Jr, & Thom, V. A. (1991). Establishing the reliability and developmental validity of a neurobehavioral assessment for preterm infants: A methodological process. Child Development, 62, 1200-1208.
42. Krueger, D. D., Howell, J. L., Hebert, B. F., Olausson, P., Taylor, J. R., & Nairn, A. C. (2006). Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology (Berlin), 189, 95-104.
43. Lakatosova, S., Celec, P., Schmidtova, E., Kubranska, A., Durdiakova, J., & Ostatnikova, D. (2011). The impact of serotonergic stimulation on reelin and glutamate decarboxylase gene expression in adult female rats. Bratislavske Lekarske Listy, 112, 58-62.
44. Lesch, K. P., Wolozin, B. L., Estler, H. C., Murphy, D. L., & Riederer, P. (1993). Isolation of a cDNA encoding the human brain serotonin transporter. Journal of Neural Transmission. General Section, 91, 67-72.
45. Liu, Y., Chen, P. L., McGrath, J., Wolyniec, P., Fallin, D., Nestadt, G., ... Avramopoulos, D. (2010). Replication of an association of a common variant in the reelin gene (RELN) with schizophrenia in Ashkenazi Jewish women. Psychiatric Genetics, 20, 184-186.
46. Lugli, G., Krueger, J. M., Davis, J. M., Persico, A. M., Keller, F., & Smalheiser, N. R. (2003). Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochemistry, 4, 9.
47. Lussier, A. L., Romay-Tallon, R., Kalynchuk, L. E., & Caruncho, H. J. (2010). Reelin as a putative vulnerability factor for depression: Examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice. Neuropharmacology, 60, 1064-1074.
48. Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C., & Paul, I. A. (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology, 31, 47-57.
49. Meyer, G., Perez-Garcia, C. G., Abraham, H., & Caput, D. (2002). Expression of p73 and reelin in the developing human cortex. Journal of Neuroscience, 22, 4973-4986.
50. Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R. E., & Oberlander, T. F. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry, 163, 1026-1032.
51. Oberlander, T. F., Bonaguro, R. J., Misri, S., Papsdorf, M., Ross, C. J., & Simpson, E. M. (2008). Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Molecular Psychiatry, 13, 65-73.
52. Oberlander, T. F., Gingrich, J. A., & Ansorge, M. S. (2009). Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: Molecular to clinical evidence. Clinical Pharmacology and Therapeutics, 86, 672-677.
53. Oberlander, T. F., Papsdorf, M., Brain, U. M., Misri, S., Ross, C., & Grunau, R. E. (2010). Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Archives of Pediatrics and Adolescent Medicine, 164, 444-451.
54. Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006). Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry, 63, 898-906.
55. Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics, 3, 97-106.
56. Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., ... Weinberger, D. R. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828-834.
57. Ramamoorthy, S., Bauman, A. L., Moore, K. R., Han, H., Yang-Feng, T., Chang, A. S., ... Blakely, R. D. (1993). Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proceedings of the National Academy of Sciences of the United States of America, 90, 2542-2546.
58. Rogers, J. T., & Weeber, E. J. (2008). Reelin and apoE actions on signal transduction, synaptic function and memory formation. Neuron Glia Biology, 4, 259-270.
59. Romero-Calvo, I., Ocon, B., Martinez-Moya, P., Suarez, M. D., Zarzuelo, A., Martinez-Augustin, O., & de Medina, F. S. (2010). Reversible Ponceau staining as a loading control alternative to actin in Western blots. Analytical Biochemistry, 401, 318-320.
60. Samama, B., & Boehm, N. (2005). Reelin immunoreactivity in lymphatics and liver during development and adult life. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 285, 595-599.
61. Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., ... Darvasi, A. (2008). Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genetics, 4, e28.
62. Smalheiser, N. R., Costa, E., Guidotti, A., Impagnatiello, F., Auta, J., Lacor, P., ... Pappas, G. D. (2000). Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 1281-1286.
63. Tissir, F., & Goffinet, A. M. (2003). Reelin and brain development. Nature Reviews. Neuroscience, 4, 496-505.
64. Weaver, K. J., Paul, I. A., Lin, R. C., & Simpson, K. L. (2010). Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: Dose-dependent effects. Anatomical Record (Hoboken), 293, 1920-1932.
65. Wisner, K. L., Sit, D. K., Hanusa, B. H., Moses-Kolko, E. L., Bogen, D. L., Hunker, D. F., ... Singer, L. T. (2009). Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes. American Journal of Psychiatry, 166, 557-566.